Kenya traces contacts and flight travellers after first imported Bundibugyo Ebola case

Kenya confirmed its first imported Bundibugyo Ebola case on October 6 after an infected patient who had travelled from the Democratic Republic of Congo died in Nairobi.

The diagnosis is also the country’s first confirmed case of Ebola Bundibugyo virus disease. It has prompted two related parts of the public-health response: monitoring people already identified as contacts and locating the passengers and crew who shared the patient’s flight to Kenya.

Health Cabinet Secretary Aden Duale announced the confirmation after laboratory testing. The Ministry of Health classified the infection as an imported case, allAfrica reported.

The patient tested positive and later died in Nairobi. These facts establish that a person infected with Bundibugyo virus died, but they do not establish Ebola as the specific cause of death.

The patient travelled from the DRC through Uganda

The patient was a Kenyan citizen who had lived in the Democratic Republic of Congo for seven years. He became ill about a month before returning to Kenya and received care at several health facilities in the DRC. His medical history and cross-border journey became central to the tracing operation once the infection was confirmed.

He travelled overland from the DRC to Kampala, Uganda, and then boarded a flight that arrived in Nairobi on October 3. Uganda forms part of the travel chronology, but the route does not show where he acquired the virus or establish a confirmed infection in Uganda connected to his journey.

After landing at Jomo Kenyatta International Airport, the patient underwent routine public-health screening and proceeded through the airport. A relative and a friend then took him to a hospital in Nairobi.

Clinicians later suspected a viral haemorrhagic fever after considering his condition and travel history. They collected a sample, and laboratory testing identified Ebola Bundibugyo virus, Hiiraan Online reported.

The sequence separates routine border screening from clinical diagnosis. The patient passed through the screening process on arrival, while confirmation followed a medical examination and laboratory analysis. The infection was therefore not detected during airport screening.

His route gives the tracing operation an international dimension. The relevant journey began in the DRC, continued by road to Uganda and ended with a commercial flight into Kenya. Follow-up consequently extends beyond relatives and healthcare workers in Nairobi to people who travelled aboard the same aircraft.

Contact monitoring and flight tracing cover different groups

Kenyan authorities identified at least 28 contacts, including members of the patient’s family and healthcare workers. Being classified as a contact places a person within the public-health follow-up process. It does not mean that the person has tested positive, developed symptoms or contracted the virus.

Officials were separately tracing people who travelled on the same aircraft:

• At least 28 known contacts, including relatives and healthcare workers, had already been identified for follow-up.
• Twenty-three passengers and four crew members from the flight were being traced by the authorities.

These figures describe the reach of the response, not a count of infections. No positive result has been confirmed among the passengers or crew, while inclusion among the identified contacts does not by itself prove exposure to infectious bodily fluids.

The distinction provides a clearer picture of the immediate situation. Kenya has confirmed one imported infection. The other numbers refer to people who require identification, monitoring or assessment because of their connection to the patient.

The response spans several settings associated with the journey and the period after arrival. Relatives and healthcare workers make up part of the known contact group, while the aircraft presents a separate task because its passengers and crew may no longer be in one place. Authorities must therefore combine direct monitoring with efforts to locate everyone linked to the flight.

The Bundibugyo strain limits the available medical tools

The virus species presents a significant public-health challenge. The Bundibugyo strain involved in the current outbreak in the DRC has no approved vaccine or specific treatment. Medical tools developed for another Ebola virus species cannot automatically be treated as approved for Bundibugyo.

The response described in Kenya therefore centres on diagnosis, isolation, infection-control procedures, contact identification and tracing. Supportive clinical care may address a patient’s condition, but it is not the same as a treatment specifically approved for this strain. The absence of an approved Bundibugyo vaccine also means vaccination is not the basis of the containment measures reported in this case.

The diagnosis illustrates the role of several layers of surveillance during cross-border travel. Routine entry checks form one layer, but clinical assessment becomes decisive when a patient’s symptoms and travel history raise concern. Laboratory analysis is then required to confirm the virus.

At this stage, the reported figures support a targeted response rather than evidence of wider transmission within Kenya. One imported case has been confirmed and the patient subsequently died. At least 28 contacts have been identified, while another 27 people connected to the flight are being traced, but neither group represents additional confirmed infections.

Featured image. Source: Pexels. Credit: Cedric Fauntleroy. License: Pexels License.